Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
First Claim
Patent Images
1. A method comprising:
- selecting a patient suffering from a heart condition;
selecting cells capable of promoting function of a heart of the patient, the cells selected from the group consisting of;
bone marrow progenitor cells, genetically-modified bone marrow progenitor cells, and myoblasts;
administering the cells to the patient;
applying an electrical current to a site of the patient in a vicinity of parasympathetic nervous tissue, wherein applying the current comprises initiating application of the current before administering the cells, and applying the current only within 48 hours of a time of administering the cells; and
configuring the current to stimulate the parasympathetic nervous tissue to reduce arrhythmia that may be caused by administration of the cells, wherein cardiac repair is facilitated, blood supply is enhanced and/or angiogenesis is enhanced.
4 Assignments
0 Petitions
Accused Products
Abstract
A method is provided including selecting a patient suffering from a condition, administering cells to the patient selected from the group consisting of: progenitor cells and genetically-modified cells, applying an electrical current to a site of the patient in a vicinity of nervous tissue, and configuring the current to stimulate the nervous tissue. Other embodiments are also described.
-
Citations
18 Claims
-
1. A method comprising:
- selecting a patient suffering from a heart condition;
selecting cells capable of promoting function of a heart of the patient, the cells selected from the group consisting of;
bone marrow progenitor cells, genetically-modified bone marrow progenitor cells, and myoblasts;administering the cells to the patient;
applying an electrical current to a site of the patient in a vicinity of parasympathetic nervous tissue, wherein applying the current comprises initiating application of the current before administering the cells, and applying the current only within 48 hours of a time of administering the cells; and
configuring the current to stimulate the parasympathetic nervous tissue to reduce arrhythmia that may be caused by administration of the cells, wherein cardiac repair is facilitated, blood supply is enhanced and/or angiogenesis is enhanced. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
- selecting a patient suffering from a heart condition;
-
10. A method comprising:
- selecting a patient suffering from a heart condition;
selecting cells capable of promoting function of a heart of the patient, the cells selected from the group consisting of;
bone marrow progenitor cells , genetically-modified bone marrow progenitor cells, and myoblasts;
administering the cells to the patient;
applying an electrical current to a site of the patient in a vicinity of parasympathetic nervous tissue, wherein applying the current comprises initiating application of the current before administering the cells, and assessing, prior to administering the cells, a response of the patient to the application of the current, and modifying an administration parameter of the administration of the cells in response to the assessment; and
configuring the current to stimulate the parasympathetic nervous tissue to reduce arrhythmia that may be caused by administration of the cells,wherein cardiac repair is facilitated, blood supply is enhanced and/or angiogenesis is enhanced. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
- selecting a patient suffering from a heart condition;
Specification